Table 1.
Type | Age, y | Women | Reason for visit/heart disease | Tests performed | Treatment | Follow-up, mo | ||||
---|---|---|---|---|---|---|---|---|---|---|
New, in-person |
76 (27) |
59 ± 19 |
38 (61.3) |
Chest pain |
12 (19.3) |
Electrocardiogram |
53 (85.5) |
Discharge |
35 (56.2) |
8 ± 10 |
Symptoms of HF |
6 (9.7) |
TTE |
40 (64.5) |
Treatment changes |
8 (12.9) |
|||||
Palpitations |
11 (17.7) |
Stress test |
5 (6.5) |
Additional tests |
21 (33.8) |
|||||
Dizziness/syncope |
3 (4.8) |
|||||||||
Murmur |
3 (4.8) |
|||||||||
ECG abnormalities |
9 (14.5) |
|||||||||
Family screening |
9 (14.5) |
|||||||||
Other |
9 (14.5) |
|||||||||
Follow-up visits, telemedicine visit | 202 (73) | 66 ± 17 | 78 (41.1) | Ischemic heart disease |
50 (26.3) |
— |
Discharge |
38 (20.0) |
9 ± 5 | |
Valvular heart disease |
35 (18.4) |
Treatment changes |
42 (22.1) |
|||||||
HF |
23 (12.1) |
Additional tests |
106 (55.8) |
|||||||
Cardiomyopathies |
17 (8.9) |
|||||||||
Arrhythmias |
38 (20) |
|||||||||
Congenital heart disease |
9 (4.7) |
|||||||||
Pulmonary hypertension |
5 (2.6%) |
|||||||||
Other | 13 (6.8) |
ECG, electrocardiography; HF, heart failure; TTE, transthoracic echocardiography.
The values are expressed as No. (%) or mean ± standard deviation.